Literature DB >> 19255280

Transplacental passage of ritonavir-boosted darunavir in two pregnant women.

D Ripamonti, D Cattaneo, M Cortinovis, F Maggiolo, F Suter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19255280     DOI： 10.1258/ijsa.2008.008515

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN： 0956-4624            Impact factor:   1.359


× No keyword cloud information.
  4 in total

Review 1.  HIV protease inhibitors in pregnancy : pharmacology and clinical use.

Authors:  Nisha Andany; Mona R Loutfy
Journal:  Drugs       Date:  2013-03       Impact factor: 9.546

Review 2.  Protecting the fetus against HIV infection: a systematic review of placental transfer of antiretrovirals.

Authors:  Shelley A McCormack; Brookie M Best
Journal:  Clin Pharmacokinet       Date:  2014-11       Impact factor: 6.447

3.  Pharmacologic and nonpharmacologic options for the management of HIV infection during pregnancy.

Authors:  Carmen D Zorrilla; Vivian Tamayo-Agrait
Journal:  HIV AIDS (Auckl)       Date:  2009-12-08

4.  Total and unbound darunavir pharmacokinetics in pregnant women infected with HIV-1: results of a study of darunavir/ritonavir 600/100 mg administered twice daily.

Authors:  C D Zorrilla; R Wright; O O Osiyemi; S Yasin; B Baugh; K Brown; B Coate; P Verboven; J Mrus; R Falcon; T N Kakuda
Journal:  HIV Med       Date:  2013-06-03       Impact factor: 3.180
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.